Nathan Vandergrift

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Results

Filter by Type

Filter by Year

Filter by Focus Area

Filter by Solution

Search Results

IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells

Marginal modeling in community randomized trials with rare events: Utilization of the negative binomial regression model

HIV-1 envelope mimicry of host enzyme kynureninase does not disrupt tryptophan metabolism

Planning in middle childhood: Early predictors and later outcomes

Analysis of low-frequency mutations associated with drug resistance to raltegravir before antiretroviral treatment

Initiation of HIV neutralizing B cell lineages with sequential envelope immunizations

HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions

Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmission

Do effects of early child care extend to age 15 years?: Results from the NICHD study of early child care and youth development

Measurement of post-war coping and stress responses: A study of Bosnian adolescents

Language comprehension in boys with fragile X syndrome and boys with Down syndrome

Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide

Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract

HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteria

Transcriptional and posttranscriptional regulation of cytokine gene expression in HIV-1 antigen-specific CD8+ T cells that mediate virus inhibition

SAS for Monte Carlo studies: A guide for quantitative researchers

Immune perturbations in HIV-1-infected individuals who make broadly neutralizing antibodies

Immunogenicity of NYVAC prime-protein boost Human Immunodeficiency Virus type 1 envelope vaccination and Simian-Human Immunodeficiency Virus challenge of nonhuman primates

Antigenicity and immunogenicity of transmitted/founder, consensus, and chronic envelope glycoproteins of human immunodeficiency virus type 1

Community-level determinants of stakeholder perceptions of community stigma toward people with opioid use disorders, harm reduction services and treatment in the HEALing Communities Study